Cargando…
Inflammasome pathway in kidney transplantation
Kidney transplantation is the best available renal replacement therapy for patients with end-stage kidney disease and is associated with better quality of life and patient survival compared with dialysis. However, despite the significant technical and pharmaceutical advances in this field, kidney tr...
Autores principales: | Granata, Simona, La Russa, Daniele, Stallone, Giovanni, Perri, Anna, Zaza, Gianluigi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10663322/ https://www.ncbi.nlm.nih.gov/pubmed/38020086 http://dx.doi.org/10.3389/fmed.2023.1303110 |
Ejemplares similares
-
mTOR-inhibitors and post-transplant diabetes mellitus: a link still debated in kidney transplantation
por: Granata, Simona, et al.
Publicado: (2023) -
Skin cancer in solid organ transplant recipients: still an open problem
por: Granata, Simona, et al.
Publicado: (2023) -
Proteomic analysis of urinary extracellular vesicles of kidney transplant recipients with BKV viruria and viremia: A pilot study
por: Bruschi, Maurizio, et al.
Publicado: (2022) -
mTOR-Inhibition and COVID-19 in Kidney Transplant Recipients: Focus on Pulmonary Fibrosis
por: Granata, Simona, et al.
Publicado: (2021) -
Association between NLRP3 rs10754558 and CARD8 rs2043211 Variants and Susceptibility to Chronic Kidney Disease
por: La Russa, Antonella, et al.
Publicado: (2023)